8i Acquisition 2 Corp. announced the pricing of its $75 million IPO and its shares are expected to begin trading on the Nasdaq under the symbol “LAXXU” Monday, November 22nd.
The new SPAC aims to combine with a target that will benefit from globalization, possesses a competitive advantage, and is at an inflection point. 8i Acquisition 2 Corp. is led by CEO and Chairman Meng Dong (James) Tan, and CFO Guan Hong (William) Yap.
Total SPAC deal count for 2021 year-to-date is now 554. This offering is expected to close on Wednesday, November 24th.
Maxim Group LLC is serving as the sole book-running manager for the offering. Loeb & Loeb LLP is serving as Issuer’s Counsel with Hunter Taubman Fischer & Li LLC serving as Underwriter’s Counsel. UHY LLP serves as auditor. American Stock Transfer & Trust Company is acting as trustee.
Launch Two (NASDAQ:LPBBU) has filed for a $200 million IPO that shows how the market has shifted for new issuance since its sister SPAC Launch One (NASDAQ:LPAAU) filed just over a month ago. Both SPACs are underwritten by Cantor Fitzgerald and seeking nominally the same raise at IPO, but Launch Two is overfunding its trust...
FTAC Emerald (NASDAQ:EMLD) has entered into a definitive agreement to combine with crypto fintech firm Fold at an enterprise value of $381 million. Phoenix, Arizona-based Fold provides digital banking services backed by a treasury of Bitcoin that includes FDIC-secured checking accounts as well Bitcoin trading and awards. The combined company is expected to trade on...
At the SPAC of Dawn Dealmakers remain confident that AI is going to play a big role in their M&A processes, but feel unprepared for some the changes, according to a new survey of 225 corporate and 75 private equity transactions professionals. SS&C subsidiary Mergermarket generated the report that found more than half of respondents...
Trailblazer Merger I (NASDAQ:TBMC) has entered into a definitive agreement to combine with data intelligence firm Cyabra at an enterprise value of $70 million. Tel Aviv-based Cyabra provides tools to corporations and governments to identify fake accounts and combat social media disinformation. The combined company is expected to trade on the Nasdaq once the deal...
Chain Bridge I (NASDAQ:CBRG) has entered into a definitive agreement to combine with cannabinoid pharmaceuticals firm Phytanix Bio at a pre-deal valuation of $58 million. Santa Barbara, California-based Phytanix is working to develop bladder and seizure treatments using cannabis-based substances. The combined company is expected to trade on the Nasdaq under the symbol “PHYX” once...